Synereca Pharmaceutics Inc., of Oklahoma City, said it raised $1.4 million from a convertible debt financing led by Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma Inc., with participation from i2E, Inc., a nationally recognized private not-for-profit corporation focused on growing innovative small businesses in Oklahoma and private investors.